Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded

The vast entity of the aging process must be well thought out while consideringoptimal management for elderly patients with cancer. Co-morbidity and functional statusare the key factors which determine the overall survival of patients. Multidisciplinaryapproaches to patient management must be emphas...

Full description

Bibliographic Details
Main Authors: Namrata Nandkumar Patil, Abhishek Singh Nayyar, Vijay Wadhwan, Tadakamadla Mahesh Babu
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2013-07-01
Series:Middle East Journal of Cancer
Subjects:
Online Access:http://mejc.sums.ac.ir/index.php/mejc/article/view/6/2
id doaj-b13a5687fedd4319aeaeaf46f802a399
record_format Article
spelling doaj-b13a5687fedd4319aeaeaf46f802a3992020-11-25T02:21:01ZengShiraz University of Medical SciencesMiddle East Journal of Cancer 2008-67092008-66872013-07-01439599Unveiling the Pathogenesis of Geriatric Oncology: Mystery UnfoldedNamrata Nandkumar PatilAbhishek Singh NayyarVijay WadhwanTadakamadla Mahesh BabuThe vast entity of the aging process must be well thought out while consideringoptimal management for elderly patients with cancer. Co-morbidity and functional statusare the key factors which determine the overall survival of patients. Multidisciplinaryapproaches to patient management must be emphasized and stressed to deal with end-of-life issues. Researchers need to identify elderly people who are most susceptible totreatment toxicities and must deal with palliation and hospice care for these patients.One approach to the issue of aging as a variable in treatment outcome would be to utilizeprograms and facilities supported by cancer institutes to address age-related questionsin clinical trials. Academic oncologists, geriatricians and pathologists can createrealistic and imminent goals to achieve victory against cancer and provide optimaltreatment that includes adequate supportive care and reduces the burden of post-treatment morbidities that compromise quality of life in these patients. This reviewfocuses on the basis of cancers that affect the elderly and how momentous advancescan be obtained to expound the pathways most critically involved in tumor developmentand progression. Through this review, an attempt has been made to explain the impactof peculiar mutations and altered cell behavior underlying geriatric oncogenesis.http://mejc.sums.ac.ir/index.php/mejc/article/view/6/2CancerCo-morbidityMutationsGeriatricMultidisciplinaryPalliationSupportive care
collection DOAJ
language English
format Article
sources DOAJ
author Namrata Nandkumar Patil
Abhishek Singh Nayyar
Vijay Wadhwan
Tadakamadla Mahesh Babu
spellingShingle Namrata Nandkumar Patil
Abhishek Singh Nayyar
Vijay Wadhwan
Tadakamadla Mahesh Babu
Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded
Middle East Journal of Cancer
Cancer
Co-morbidity
Mutations
Geriatric
Multidisciplinary
Palliation
Supportive care
author_facet Namrata Nandkumar Patil
Abhishek Singh Nayyar
Vijay Wadhwan
Tadakamadla Mahesh Babu
author_sort Namrata Nandkumar Patil
title Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded
title_short Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded
title_full Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded
title_fullStr Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded
title_full_unstemmed Unveiling the Pathogenesis of Geriatric Oncology: Mystery Unfolded
title_sort unveiling the pathogenesis of geriatric oncology: mystery unfolded
publisher Shiraz University of Medical Sciences
series Middle East Journal of Cancer
issn 2008-6709
2008-6687
publishDate 2013-07-01
description The vast entity of the aging process must be well thought out while consideringoptimal management for elderly patients with cancer. Co-morbidity and functional statusare the key factors which determine the overall survival of patients. Multidisciplinaryapproaches to patient management must be emphasized and stressed to deal with end-of-life issues. Researchers need to identify elderly people who are most susceptible totreatment toxicities and must deal with palliation and hospice care for these patients.One approach to the issue of aging as a variable in treatment outcome would be to utilizeprograms and facilities supported by cancer institutes to address age-related questionsin clinical trials. Academic oncologists, geriatricians and pathologists can createrealistic and imminent goals to achieve victory against cancer and provide optimaltreatment that includes adequate supportive care and reduces the burden of post-treatment morbidities that compromise quality of life in these patients. This reviewfocuses on the basis of cancers that affect the elderly and how momentous advancescan be obtained to expound the pathways most critically involved in tumor developmentand progression. Through this review, an attempt has been made to explain the impactof peculiar mutations and altered cell behavior underlying geriatric oncogenesis.
topic Cancer
Co-morbidity
Mutations
Geriatric
Multidisciplinary
Palliation
Supportive care
url http://mejc.sums.ac.ir/index.php/mejc/article/view/6/2
work_keys_str_mv AT namratanandkumarpatil unveilingthepathogenesisofgeriatriconcologymysteryunfolded
AT abhisheksinghnayyar unveilingthepathogenesisofgeriatriconcologymysteryunfolded
AT vijaywadhwan unveilingthepathogenesisofgeriatriconcologymysteryunfolded
AT tadakamadlamaheshbabu unveilingthepathogenesisofgeriatriconcologymysteryunfolded
_version_ 1724868097318322176